Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
...openia- -No Serious Adverse Events or Immunogenicity to Date- REDWOOD CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ) today announced positive progress in its Phase IIa trial of MAXY-G34 for the treatment of chemotherapy-induced neutropenia. Initial observations fro...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...K.: BGC) COUGAR BIOTECHNOLOGY INC (NASDAQ: CGRB ) EXELIXIS INC (NASDAQ: EXEL ) LIGAND PHARMACEUTICALS INC (NASDAQ: LGND ) MAXYGEN INC (NASDAQ: maxy ) MOLECULAR INSIGHT PHARM INC (NASDAQ: MIPI ) MORPHOSYS (Frankfurt, Germany: MOR) NEKTAR THERAPEUTICS (NASDAQ: NKTR ) PROTHERICS (London Main Ma...Maxygen to Present at the Cowen & Company 28th Annual Health Care Conference
... REDWOOD CITY, Calif., March 11 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the Cowen & Company 28th Annu...Maxygen Announces Management Changes
... REDWOOD CITY, Calif., March 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today announced changes to its management team. Grant Yonehiro, Maxyg...Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
... REDWOOD CITY, Calif., Feb. 12 /PRNewswire-FirstCall/ . Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today reported financial results for the fourth quarter and year ende...Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference
... REDWOOD CITY, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the Roth 20th Annual OC Growt...Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
... REDWOOD CITY, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the Stanford Group Company 13...Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
... REDWOOD CITY, Calif., Dec. 28 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the JPMorgan 26th Annual Heal...Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
... REDWOOD CITY, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ), a biotechnology company focused on the development of improved protein drugs, announced today the license of its proprietary dengue virus antigen t...Maxygen Reports Third Quarter 2007 Financial Results
... REDWOOD CITY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: maxy ) today reported financial results for the quarter ended September 30, 2007. Maxygen reported a net loss of $14.7 million, or $0.40 per share, for the...